MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0019514
Amol Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹119.9 Cr
▲ 5% YoY
Net profit · FY 2025
₹6.16 Cr
Net margin 5.1%
EBITDA · FY 2025
₹7.55 Cr
EBITDA margin 6.3%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹66.5 Lakh
Issued & subscribed
Open charges
₹65.96 Cr
Satisfied ₹36.74 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
316
Provident fund records
About Amol Pharmaceuticals Private Limited
Data last updated:
Amol Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24230RJ1996PTC097657. Its GSTIN is 08AAACA6091J1ZK (Rajasthan). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹66.5 Lakh. It is led by directors Sandeep Sapra (Managing Director) and Ashok Luhadia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹119.9 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹6.16 Cr (net margin 5.1%) and EBITDA of ₹7.55 Cr (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
The company has about 316 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Amol Pharma. As per MCA filings, the company has open charges of ₹65.96 Cr and satisfied charges of ₹36.74 Cr on record.
Amol Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0019514). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amolpharma.com.
Company details
CIN U24230RJ1996PTC097657
Registration Number 097657
Incorporation Date 12 February 1996
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0019514
CIN history
Amol Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH1996PTC097178. The current CIN is U24230RJ1996PTC097657, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230RJ1996PTC097657 | Current |
| U24230MH1996PTC097178 | Previous |
Recognitions & Rankings of Amol Pharmaceuticals
Contact details
Amol Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its website is amolpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressE – 1 362 – 363 – 364 – 365, Sanganer, Jaipur, Rajasthan, India – 302022
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Amol Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Amol Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amol Pharmaceuticals operates one associated brand: Amol Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Custom developer and manufacturer of premium dietary supplements and ingredients. | amolpharma.com |
Business activity
The main business activity of Amol Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amol Pharmaceuticals Private Limited, buy the company report.
Financials of Amol Pharmaceuticals Private Limited
FY 2025 filings availableAmol Pharmaceuticals Private Limited reported revenue of ₹119.9 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹119.9 Cr ▲ 5%
Net profit · FY 2025
₹6.16 Cr margin 5.1%
EBITDA · FY 2025
₹7.55 Cr margin 6.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 1%
EBITDA CAGR growth
3 years · compounded
▼ 28%
Revenue has grown at a compounded annual rate (CAGR) of 1% over three years, including 5% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 5.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amol Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amol Pharmaceuticals Private Limited
Amol Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Sapra | Managing Director | 01 Mar 1996 | 30 Years 8 Months | Current |
| Ashok Luhadia Also directs: Amol Properties Private Limited | Director | 12 Feb 1996 | 30 Years 8 Months | Current |
Peer comparison
Amol Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Healthcare industry (Formulations, Pharmaceuticals, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shine Pharmaceuticals Limited | ₹120.09 Cr (FY 2025) | -4.0% | Vadodara, Gujarat, India | |||
| Vartika Chemicals & Pharmaceuticals Private Limited | ₹120.07 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Ananta Medicare Limited | ₹120.04 Cr (FY 2025) | 50.0% | Delhi, India | |||
| Amol Pharmaceuticals Private Limitedthis company | ₹119.9 Cr (FY 2025) | ₹6.16 Cr | 5.1% | 5.0% | 316 | Jaipur, Rajasthan, India |
| Alvita Pharma Private Limited | ₹119.83 Cr (FY 2024) | 7.0% | Ahmedabad, Gujarat, India | |||
| M J Biopharm Private Limited | ₹119.1 Cr (FY 2017) | 9.0% | Mumbai, Maharashtra, India | |||
| Pell Tech Health Care Private Limited | ₹118.72 Cr (FY 2025) | 16.0% | Thane, Maharashtra, India |
To see the full peer comparison of Amol Pharmaceuticals Private Limited, buy the company report.
Auditor
Amol Pharmaceuticals Private Limited is audited by SCLJ & Associates for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SCLJ & Associates | FY 2025 | 036048C |
Shareholding
The shareholding of Amol Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amol Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹65.96 Cr
Satisfied charges
₹36.74 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2024 | 100911310 | Others | ₹96.3 Lakh | Open | |
| 23 Dec 2020 | 100411737 | Hdfc Bank Limited | ₹65 Cr | Open | |
| 22 Jul 2020 | 100362597 | State Bank of India | ₹4.13 Cr | Satisfied | |
| 07 Apr 2020 | 100333081 | State Bank of India | ₹2.4 Cr | Satisfied | |
| 10 Feb 1997 | 90150434 | State Bank of India | ₹29.46 Cr | Satisfied |
To see the full charge records of Amol Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving Amol Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Amol Pharmaceuticals Private Limited was last rated by Care on 16 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 16 Mar 2022 |
To see the full credit ratings and regulatory alerts of Amol Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
Amol Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Prakruti Products Private Limited | |||
| Sigachi Industries Limited | |||
| The Gwalior Forest Products Limited. |
To see the full MSME payment records of Amol Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Amol Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Amol Properties Private Limited | U45200MH2003PTC142320 |
To see the full group structure of Amol Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Amol Pharmaceuticals Private Limited has a workforce of 316 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
Employee count
316
Active EPFO establishments
1
Employee growth
7.48%
GST
Amol Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACA6091J1ZK | Rajasthan | Active | 01 Jul 2017 |
| 27AAACA6091J2ZJ | Maharashtra | Active | 09 May 2019 |
To see the full GST registrations and return filing status of Amol Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amol Pharmaceuticals Private Limited has 7 board changes on record since 1996: 2 appointments and 5 cessations. The latest: Amol Luhadia ceased to be Director on 03 Jul 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 6,500.00 Lakh registered on 23 Dec 2020 with Charge ID 100411737 was modified on 16 Feb 2026.
AGM
Amol Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Amol Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Others amounted to Rs. 96.30 Lakh with Charge ID 100911310 was registered on 20 Apr 2024.
Ceased
Amol Luhadia ceased to be Director.
Charges
A charge registered on 22 Jul 2020 via Charge ID 100362597 with State Bank Of India was fully satisfied on 01 Jun 2021.
Charges
A charge registered on 07 Apr 2020 via Charge ID 100333081 with State Bank Of India was fully satisfied on 01 Jun 2021.
Charges
A charge registered on 10 Feb 1997 via Charge ID 90150434 with State Bank Of India was fully satisfied on 01 Jun 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6,500.00 Lakh with Charge ID 100411737 was registered on 23 Dec 2020.
Charges
A charge with State Bank Of India amounted to Rs. 413.00 Lakh with Charge ID 100362597 was registered on 22 Jul 2020.
Charges
A charge with State Bank Of India amounted to Rs. 240.00 Lakh with Charge ID 100333081 was registered on 07 Apr 2020.
Charges
A charge with State Bank Of India of Rs. 2,946.00 Lakh registered on 10 Feb 1997 with Charge ID 90150434 was modified on 26 Feb 2020.
12 earlier events are in the company report.
Frequently asked questions
Amol Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 1996 (30+ years old) and is registered under CIN U24230RJ1996PTC097657.
Amol Pharmaceuticals has 2 current directors:
- Sandeep Sapra - Managing Director
- Ashok Luhadia - Director
The latest financial statements of Amol Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amol Pharmaceuticals is 08AAACA6091J1ZK, registered in Rajasthan. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACA6091J2ZJ (Maharashtra).
The CIN (Corporate Identification Number) of Amol Pharmaceuticals is U24230RJ1996PTC097657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amol Pharmaceuticals was incorporated on 12 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Amol Pharmaceuticals by revenue are Shine Pharmaceuticals Limited, Vartika Chemicals & Pharmaceuticals Private Limited, Ananta Medicare Limited, Alvita Pharma Private Limited, M J Biopharm Private Limited and 1 more, all in the Healthcare industry (Formulations, Pharmaceuticals, Preventive Healthcare Supplements), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amol Luhadia ceased to be Director on 03 Jul 2023. Dhanpatrai Luhadia ceased to be Director on 30 Sep 2013. Shobha Luhadia ceased to be Director on 30 Sep 2013. Amol Pharmaceuticals has 7 board changes on record in total.
Yes, Amol Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0019514).
Amol Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 4 overdue payments to 3 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Amol Pharmaceuticals can be reached through the website amolpharma.com. Its registered office is in Jaipur, Rajasthan, India.
The registered office of Amol Pharmaceuticals is at E – 1 362 – 363 – 364 – 365, Sanganer, Jaipur, Rajasthan, India – 302022.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages